{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:17:29Z","timestamp":1783048649033,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0108674h0003"],"award-info":[{"award-number":["JP23fk0108674h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jiac.2026.102993","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:08:22Z","timestamp":1778576902000},"page":"102993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive role of T-Spot.TB in evaluating active tuberculosis: a retrospective cohort study in a tertiary-care hospital in a low-burden country"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6071-1297","authenticated-orcid":false,"given":"Takashi","family":"Urushibara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7849-4563","authenticated-orcid":false,"given":"Michito","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Herai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-6930","authenticated-orcid":false,"given":"Misuzu","family":"Yahaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7732-9870","authenticated-orcid":false,"given":"Toshibumi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-9320","authenticated-orcid":false,"given":"Eiji","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-3458","authenticated-orcid":false,"given":"Hidetoshi","family":"Igari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102993_bib1","series-title":"Global tuberculosis report 2023","year":"2023"},{"key":"10.1016\/j.jiac.2026.102993_bib2","series-title":"WHO consolidated guidelines on tuberculosis: module 3: diagnosis","year":"2024"},{"key":"10.1016\/j.jiac.2026.102993_bib3","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection \u2014 united States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jiac.2026.102993_bib4","unstructured":"Centers for Disease Control and Prevention. Clinical testing guidance for tuberculosis: Interferon gamma release assay, https:\/\/www.cdc.gov\/tb\/hcp\/testing-diagnosis\/interferon-gamma-release-assay.html, [accessed 29 October 2025]."},{"key":"10.1016\/j.jiac.2026.102993_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American thoracic society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102993_bib6","series-title":"Use of interferon-gamma release assays in support of TB diagnosis","year":"2011"},{"key":"10.1016\/j.jiac.2026.102993_bib7","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1093\/pubmed\/fdaf106","article-title":"A rapid review of the causes of diagnostic and treatment delays for tuberculosis in low-burden countries","volume":"47","author":"Preston","year":"2025","journal-title":"J Public Health"},{"key":"10.1016\/j.jiac.2026.102993_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB Gold plus compared with QuantiFERON-TB Gold in-tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.102993_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2026.102993_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102993_bib11","series-title":"Tuberculosis in Japan annual report 2024","year":"2025"},{"key":"10.1016\/j.jiac.2026.102993_bib12","article-title":"Delayed tuberculosis treatment and cost of care in a low-incidence country","volume":"9","author":"O'Connell","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102993_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000499052","article-title":"Delays in the diagnosis and treatment of tuberculous lymphadenitis in low-incidence countries: a systematic review","volume":"97","author":"Mathiasen","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.jiac.2026.102993_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2026.102993_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2026.102993_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"Lee","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2026.102993_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.cmi.2023.07.003","article-title":"Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis","volume":"29","author":"Zhou","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.102993_bib18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1473-3099(20)30732-5","article-title":"Measuring health-care delays among privately insured patients with tuberculosis in the USA: an observational cohort study","volume":"21","author":"El Halabi","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:43:51Z","timestamp":1783046631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1341321X26000917"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102993","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive role of T-Spot.TB in evaluating active tuberculosis: a retrospective cohort study in a tertiary-care hospital in a low-burden country","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102993"}}